Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2010 AND VI 28 AND IP 3
Results: 8
1
2
Estimation of a valuation function for a diabetes mellitus-specific preference-based measure of health: the Diabetes Utility Index.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
Varenicline: A Pharmacoeconomic Review of its Use as an Aid to Smoking Cessation.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 3, p. 231, doi. 10.2165/11204380-000000000-00000
- By:
- Publication type:
- Article
4
The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 3, p. 185, doi. 10.2165/11313640-000000000-00000
- By:
- Publication type:
- Article
5
Measuring Quality of Life for Certain Events versus Pre-Specified Points in Time.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 3, p. 171, doi. 10.2165/11530990-000000000-00000
- By:
- Publication type:
- Article
6
Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the $50 000 Threshold in the US.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 3, p. 175, doi. 10.2165/11530650-000000000-00000
- By:
- Publication type:
- Article
7
Estimation of a Valuation Function for a Diabetes Mellitus-Specific Preference-Based Measure of Health.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 3, p. 201, doi. 10.2165/11313990-000000000-00000
- By:
- Publication type:
- Article
8
Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 3, p. 217, doi. 10.2165/11531480-000000000-00000
- By:
- Publication type:
- Article